行情

CSII

CSII

心血管系统公司
NASDAQ

实时行情|Nasdaq Last Sale

51.34
-1.49
-2.82%
盘后: 51.94 +0.6 +1.17% 16:11 01/24 EST
开盘
53.46
昨收
52.83
最高
53.46
最低
51.25
成交量
28.08万
成交额
--
52周最高
55.22
52周最低
28.59
市值
18.07亿
市盈率(TTM)
-551.4501
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CSII 新闻

  • 打造干净市容!曼谷计划2021年电缆全面地下化
  • 中国新闻网.37分钟前
  • 降息+QE还不够 美联储考虑让二战抗衰退工具重出江湖
  • 新浪财经综合.54分钟前
  • 日股收盘跌逾2% 年内涨幅抹消殆尽
  • 新浪财经.59分钟前
  • 伊朗一架客机冲出跑道停到大街上 机上130人安然无恙
  • 新浪财经.1小时前

更多

所属板块

医疗设备、用品及经销
-0.74%
医疗设备和用品
-0.90%

热门股票

名称
价格
涨跌幅

CSII 简况

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral. The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries.
展开

Webull提供Cardiovascular Systems Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。